Part 1: COVID-19 Is Here to Stay
SARS-CoV-2, the virus that causes the COVID-19 disease, has evolved, adapting and mutating as it travels across the globe. In Part 1 of this series, Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times, explains how this evolution has ensured the survival of the coronavirus and made COVID-19 a long-term threat.
Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases. He is also the chairman and chief executive of NantWorks and the owner of or investor in a number of companies, including ImmunityBio and NantKwest, which are currently researching immunotherapies for COVID-19.
Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases. He is also the chairman and chief executive of NantWorks and the owner of or investor in a number of companies, including ImmunityBio and NantKwest, which are currently researching immunotherapies for COVID-19.
